Log In
Print this Print this

tafetinib (SIM010603)

  Manage Alerts
Collapse Summary General Information
Company Simcere Pharmaceutical Group
DescriptionMulti-targeted receptor tyrosine kinase (RTK) inhibitor
Molecular Target Receptor tyrosine kinase (RTK)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today